Medical self-testing has become indispensable for a number of years now, but how do you actually produce these products? That process has a number of snags. Companies are often very good at detecting diseases, they just get stuck on the production process. "That's where we specialise," explains Bondus founder Bas-Jan Hoogenberg.
Both Bas-Jan and his co-founder Sven Eijpe were involved in producing medical products in their previous jobs. "That process is very close. You can only work with safe materials that do not affect such a test. In addition, a medical self-test must also be leak-proof: the test fluid must not come out of the product, because then it won't work. This makes it difficult to produce medical self-tests on a large scale."
Link
Bondus' solution? The name gives that away: a new way of making connections between materials. "We have designed a process that allows us to connect materials together on a very small scale. These are plastics that you glue together, as it were. Between those layers of plastic is then a network of channels through which liquids flow."
According to Bas-Jan, Bondus' technology is best compared to a circuit board. "In a circuit board, there are copper tracks that conduct the current through the chip. We do not work with those copper tracks, but with liquid tracks. Anything is possible with our technology: mixing liquids, or letting them flow past a sensor and extracting data from it."
Faster to market
Bondus' technology has a big advantage: customers can enter the market faster. "Companies in the medical sector are logically very focused on the part they do themselves: detecting diseases. That is also a crucial part of a test, of course! But if you don't think about manufacturing, you are not scalable. And no company gets happy with too low a production capacity."
Bondus is not involved in the disease detection component, but is involved in the subsequent processes. "Both with our technology and with our advice. How do you make the right choices in your design process, to make sure later that you can produce millions of tests?"
Niche market
The world of medical self-testing is a niche market and that is often a difficult target group to convince. "You would expect that our customers would prefer to change as little as possible because they already use reliable methods. Anyway, pushing the medical market to innovate is very difficult. That is why I am so surprised how open our customers are to new technologies. In the end, it also makes sense: in this corner of the market, people are working on a new generation of products. They are used to trying new things, and Bondus' technology is part of that."
Startup phase
Bondus was founded in 2020. "Back then, it was really a matter of fiddling around and experimenting with materials. Later, we moved to ZWINC, the incubator for startups in Zwolle. Then you notice that things get more and more serious, until the moment we decided to work full-time for Bondus. An exciting step, but in the end it turned out to be the right one: you suddenly have your head completely free for your own company."
Now it is time for Bondus to grow further itself. "First and foremost is team expansion. With more people you simply achieve more and that is what we need. Of course, you need money for that, which is why we started looking for investors. That search brought us to Business Angels Network Nijmegen (BANN) and Briskr."
In the run-up to BANN, Bas-Jan took pitchtraining. "That helped me a lot, because it helps you get a good focus on what you are doing as a company. We also received guidance in terms of valuing our company. That's how we formed the plans for next year." This is where Bondus' big dream immediately comes into play. "When you buy a laptop, it almost always has a sticker saying 'Intel Inside'. We want that too. That you buy a medical self-test and on the back it says 'Bondus Inside'. That's what we're going for!"


